Raymond James & Associates’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
|
|||||
|
2023
Q4 | $631K | Sell |
|
|||||
|
2023
Q3 | $406K | Sell |
|
|||||
|
2023
Q2 | $556K | Sell |
|
|||||
|
2023
Q1 | $561K | Sell |
|
|||||
|
2022
Q4 | $607K | Sell |
|
|||||
|
2022
Q3 | $701K | Sell |
|
|||||
|
2022
Q2 | $399K | Sell |
|
|||||
|
2022
Q1 | $688K | Sell |
|
|||||
|
2021
Q4 | $722K | Sell |
|
|||||
|
2021
Q3 | $677K | Sell |
|
|||||
|
2021
Q2 | $652K | Sell |
|
|||||
|
2021
Q1 | $690K | Sell |
|
|||||
|
2020
Q4 | $584K | Sell |
|
|||||
|
2020
Q3 | $462K | Sell |
|
|||||
|
2020
Q2 | $667K | Buy |
|
|||||
|
2020
Q1 | $261K | Sell |
|
|||||
|
2019
Q4 | $536K | Buy |
|